Myotwin help scientists in biotech, pharmaceutical and academic research to enhance their methods of pre-clinical cardiac research. Our science-as-a-service approach is based on organoids of the human heart muscle and innovative processes that provide reproducible results in unprecedented detail for a
variety of use cases, such as drug testing. This enables our partners to increase development speed, de-risk their pre-clinical stage while simultaneously reducing the need for animal testing. Ultimately, it contributes to a more sustainable and ethical research environment. Join us on our mission to change science for the better!